-da-Silva. Gi␣3 protein-coupled dopamine D3 receptor-mediated inhibition of renal NHE3 activity in SHR proximal tubular cells is a PLC-PKC-mediated event. Am J Physiol Renal Physiol 287: F1059 -F1066, 2004. First published July 20, 2004 doi:10.1152/ajprenal.00139.2004.-This study evaluated the transduction pathway associated with type 3 Na ϩ /H ϩ exchanger (NHE3) activity-induced inhibition during dopamine D3 receptor activation in immortalized renal proximal tubular epithelial cells from the spontaneously hypertensive rat. The dopamine D3 receptor agonist 7-OH-DPAT decreased NHE3 activity, which was prevented by the D2-like receptor antagonist S-sulpiride, pertussis toxin (PTX; overnight treatment), and the PKC inhibitor chelerythrine, but not by cholera toxin (overnight treatment), the MAPK inhibitor PD-098059, or the p38 inhibitor SB-203580. The PKA inhibitor H-89 abolished the inhibitory effects of forskolin on NHE3 activity, but not that of 7-OH-DPAT. The phospholipase C (PLC) inhibitor U-73122 prevented the inhibitory effects of 7-OH-DPAT, whereas PDBu and 7-OH-DPAT increased PLC activity and reduced NHE3 activity; downregulation of PKC abolished the inhibitory effects of both PDBu and 7-OH-DPAT on NHE activity. The inhibition of NHE3 activity by GTP␥S and the prevention of the effect of 7-OH-DPAT by PTX suggest an involvement of a G i/o protein coupled to the dopamine D3 receptor. Indeed, the 7-OH-DPAT-induced decrease in NHE3 activity was abolished in cells treated overnight with the anti-Gi␣3 antibody, but not in cells treated with antibodies against Gq/11, Gs␣, G, and Gi␣1,2 proteins. The calcium ionophore A-23187 and the Ca 2ϩ -ATPase inhibitor thapsigargin increased intracellular Ca 2ϩ but did not affect NHE3 activity. However, the inhibitory effects of PDBu and 7-OH-DPAT on NHE3 activity were completely abolished by A-23287 and thapsigargin. It is concluded that inhibition of NHE3 activity by dopamine D3 receptors coupled to Gi␣3 proteins is a PLC-PKC-mediated event, modulated by intracellular Ca 2ϩ . , and D 4 ), which are differentially expressed along the nephron (12, 33). The autocrine/paracrine function of dopamine, manifested by tubular rather than by hemodynamic mechanisms, becomes most evident during extracellular fluid volume expansion (25). This renal autocrine/paracrine function is lost in essential hypertension and in some animal models of genetic hypertension (4, 22-24, 28, 45, 56). Furthermore, disruption of the D 1 or D 3 receptor produces hypertension in mice (1, 5). In some humans with essential hypertension, renal dopamine production in response to sodium loading is impaired and may contribute to the hypertension (48). However, urinary dopamine is higher in young adults with hypertension than normotensive controls, indicating abnormality at the receptor or postreceptor levels (44). The molecular basis for the dopaminergic dysfunction in hypertension is not known but may involve an abnormal posttranslational modification of the dopamine receptor. There may be a primary defect in ...